Hester Biosciences Limited (NSE:HESTERBIO)
2,076.40
+17.70 (0.86%)
Jun 19, 2026, 3:29 PM IST
Hester Biosciences Market Cap
Hester Biosciences has a market cap or net worth of 17.67 billion as of June 18, 2026. Its market cap has increased by 16.03% in one year.
Market Cap
17.67B
Enterprise Value
19.63B
Revenue
3.33B
Ranking
n/a
PE Ratio
31.75
Stock Price
2,076.40
Market Cap Chart
Since October 11, 1996, Hester Biosciences's market cap has increased from 22.04M to 17.67B, an increase of 80,040.90%. That is a compound annual growth rate of 25.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 17.67B | 30.46% |
| Dec 31, 2025 | 13.54B | -33.49% |
| Dec 31, 2024 | 20.36B | 64.06% |
| Dec 29, 2023 | 12.41B | -18.54% |
| Dec 30, 2022 | 15.24B | -29.34% |
| Dec 31, 2021 | 21.56B | 48.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 54.34B |
| Orchid Pharma | 49.66B |
| RPG Life Sciences | 37.67B |
| Solara Active Pharma Sciences | 27.13B |
| Indoco Remedies | 21.69B |
| Beta Drugs | 20.09B |
| Sakar Healthcare | 17.88B |
| Windlas Biotech | 16.84B |